Skip to main content

In Vivo Enrichment of Diabetogenic T Cells.

Citation
Thelin, M. A., et al. “In Vivo Enrichment Of Diabetogenic T Cells.”. Diabetes, pp. 2220-2229.
Center Joslin Diabetes Center
Author Martin A Thelin, Stephan Kissler, Frederic Vigneault, Alexander L Watters, Des White, Sandeep T Koshy, Sarah A Vermillion, David J Mooney, Thomas Serwold, Omar A Ali
Abstract

Dysfunctional T cells can mediate autoimmunity, but the inaccessibility of autoimmune tissues and the rarity of autoimmune T cells in the blood hinder their study. We describe a method to enrich and harvest autoimmune T cells in vivo by using a biomaterial scaffold loaded with protein antigens. In model antigen systems, we found that antigen-specific T cells become enriched within scaffolds containing their cognate antigens. When scaffolds containing lysates from an insulin-producing β-cell line were implanted subcutaneously in autoimmune diabetes-prone NOD mice, β-cell-reactive T cells homed to these scaffolds and became enriched. These T cells induced diabetes after adoptive transfer, indicating their pathogenicity. Furthermore, T-cell receptor (TCR) sequencing identified many expanded TCRs within the β-cell scaffolds that were also expanded within the pancreata of NOD mice. These data demonstrate the utility of biomaterial scaffolds loaded with disease-specific antigens to identify and study rare, therapeutically important T cells.

Year of Publication
2017
Journal
Diabetes
Volume
66
Issue
8
Number of Pages
2220-2229
Date Published
12/2017
ISSN Number
1939-327X
DOI
10.2337/db16-0946
Alternate Journal
Diabetes
PMID
28396510
PMCID
PMC5521861
Download citation